These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 20547493)

  • 1. Genetic variation in the progesterone receptor gene and risk of endometrial cancer: a haplotype-based approach.
    Lee E; Hsu C; Haiman CA; Razavi P; Horn-Ross PL; Van Den Berg D; Bernstein L; Le Marchand L; Henderson BE; Setiawan VW; Ursin G
    Carcinogenesis; 2010 Aug; 31(8):1392-9. PubMed ID: 20547493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clarifying the PROGINS allele association in ovarian and breast cancer risk: a haplotype-based analysis.
    Pearce CL; Hirschhorn JN; Wu AH; Burtt NP; Stram DO; Young S; Kolonel LN; Henderson BE; Altshuler D; Pike MC
    J Natl Cancer Inst; 2005 Jan; 97(1):51-9. PubMed ID: 15632380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progesterone receptor gene variants and risk of endometrial cancer.
    O'Mara TA; Fahey P; Ferguson K; Marquart L; Lambrechts D; Despierre E; Vergote I; Amant F; Hall P; Liu J; Czene K; ; Rebbeck TR; ; ; ; Ahmed S; Dunning AM; Gregory CS; Shah M; ; Webb PM; Spurdle AB
    Carcinogenesis; 2011 Mar; 32(3):331-5. PubMed ID: 21148628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of the progesterone receptor gene with endometrial cancer risk in a Chinese population.
    Xu WH; Long JR; Zheng W; Ruan ZX; Cai Q; Cheng JR; Xiang YB; Shu XO
    Cancer; 2009 Jun; 115(12):2693-700. PubMed ID: 19382201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Common genetic variation in IGF1 and prostate cancer risk in the Multiethnic Cohort.
    Cheng I; Stram DO; Penney KL; Pike M; Le Marchand L; Kolonel LN; Hirschhorn J; Altshuler D; Henderson BE; Freedman ML
    J Natl Cancer Inst; 2006 Jan; 98(2):123-34. PubMed ID: 16418515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progesterone receptor PROGINS and +331G/A polymorphisms confer susceptibility to ovarian cancer: a meta-analysis based on 17 studies.
    Liu T; Chen L; Sun X; Wang Y; Li S; Yin X; Wang X; Ding C; Li H; Di W
    Tumour Biol; 2014 Mar; 35(3):2427-36. PubMed ID: 24197980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haplotype-based association studies of IGFBP1 and IGFBP3 with prostate and breast cancer risk: the multiethnic cohort.
    Cheng I; Penney KL; Stram DO; Le Marchand L; Giorgi E; Haiman CA; Kolonel LN; Pike M; Hirschhorn J; Henderson BE; Freedman ML
    Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1993-7. PubMed ID: 17035411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progesterone receptor variation and risk of ovarian cancer is limited to the invasive endometrioid subtype: results from the Ovarian Cancer Association Consortium pooled analysis.
    Pearce CL; Wu AH; Gayther SA; Bale AE; ; Beck PA; Beesley J; Chanock S; Cramer DW; DiCioccio R; Edwards R; Fredericksen ZS; Garcia-Closas M; Goode EL; Green AC; Hartmann LC; Hogdall E; Kjaer SK; Lissowska J; McGuire V; Modugno F; Moysich K; Ness RB; Ramus SJ; Risch HA; Sellers TA; Song H; Stram DO; Terry KL; Webb PM; Whiteman DC; Whittemore AS; Zheng W; Pharoah PD; Chenevix-Trench G; Pike MC; Schildkraut J; Berchuck A;
    Br J Cancer; 2008 Jan; 98(2):282-8. PubMed ID: 18219286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic variation in the progesterone receptor gene and susceptibility to recurrent pregnancy loss: a case-control study.
    Bahia W; Finan RR; Al-Mutawa M; Haddad A; Soua A; Janhani F; Mahjoub T; Almawi WY
    BJOG; 2018 May; 125(6):729-735. PubMed ID: 28972310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of progesterone receptor gene (PGR) variants and breast cancer risk in African American women.
    Gabriel CA; Mitra N; Demichele A; Rebbeck T
    Breast Cancer Res Treat; 2013 Jun; 139(3):833-43. PubMed ID: 23764995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comprehensive analysis of common genetic variation in prolactin (PRL) and PRL receptor (PRLR) genes in relation to plasma prolactin levels and breast cancer risk: the multiethnic cohort.
    Lee SA; Haiman CA; Burtt NP; Pooler LC; Cheng I; Kolonel LN; Pike MC; Altshuler D; Hirschhorn JN; Henderson BE; Stram DO
    BMC Med Genet; 2007 Dec; 8():72. PubMed ID: 18053149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fine-mapping of the HNF1B multicancer locus identifies candidate variants that mediate endometrial cancer risk.
    Painter JN; O'Mara TA; Batra J; Cheng T; Lose FA; Dennis J; Michailidou K; Tyrer JP; Ahmed S; Ferguson K; Healey CS; Kaufmann S; Hillman KM; Walpole C; Moya L; Pollock P; Jones A; Howarth K; Martin L; Gorman M; Hodgson S; ; ; De Polanco MM; Sans M; Carracedo A; Castellvi-Bel S; Rojas-Martinez A; Santos E; Teixeira MR; Carvajal-Carmona L; Shu XO; Long J; Zheng W; Xiang YB; ; Montgomery GW; Webb PM; Scott RJ; McEvoy M; Attia J; Holliday E; Martin NG; Nyholt DR; Henders AK; Fasching PA; Hein A; Beckmann MW; Renner SP; Dörk T; Hillemanns P; Dürst M; Runnebaum I; Lambrechts D; Coenegrachts L; Schrauwen S; Amant F; Winterhoff B; Dowdy SC; Goode EL; Teoman A; Salvesen HB; Trovik J; Njolstad TS; Werner HM; Ashton K; Proietto T; Otton G; Tzortzatos G; Mints M; Tham E; ; Hall P; Czene K; Liu J; Li J; Hopper JL; Southey MC; ; Ekici AB; Ruebner M; Johnson N; Peto J; Burwinkel B; Marme F; Brenner H; Dieffenbach AK; Meindl A; Brauch H; ; Lindblom A; Depreeuw J; Moisse M; Chang-Claude J; Rudolph A; Couch FJ; Olson JE; Giles GG; Bruinsma F; Cunningham JM; Fridley BL; Børresen-Dale AL; Kristensen VN; Cox A; Swerdlow AJ; Orr N; Bolla MK; Wang Q; Weber RP; Chen Z; Shah M; French JD; Pharoah PD; Dunning AM; Tomlinson I; Easton DF; Edwards SL; Thompson DJ; Spurdle AB
    Hum Mol Genet; 2015 Mar; 24(5):1478-92. PubMed ID: 25378557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen receptor polymorphisms and the risk of endometrial cancer.
    Ashton KA; Proietto A; Otton G; Symonds I; McEvoy M; Attia J; Gilbert M; Hamann U; Scott RJ
    BJOG; 2009 Jul; 116(8):1053-61. PubMed ID: 19438492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic variation in CYP17 and endometrial cancer risk.
    Gaudet MM; Lacey JV; Lissowska J; Peplonska B; Brinton LA; Chanock S; Garcia-Closas M
    Hum Genet; 2008 Mar; 123(2):155-62. PubMed ID: 18172694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progesterone Receptor (PGR) Gene Variants Associated with Breast Cancer and Associated Features: a Case-Control Study.
    Ghali RM; Al-Mutawa MA; Ebrahim BH; Jrah HH; Zaied S; Bhiri H; Hmila F; Mahjoub T; Almawi WY
    Pathol Oncol Res; 2020 Jan; 26(1):141-147. PubMed ID: 29302853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comprehensive haplotype analysis of CYP19 and breast cancer risk: the Multiethnic Cohort.
    Haiman CA; Stram DO; Pike MC; Kolonel LN; Burtt NP; Altshuler D; Hirschhorn J; Henderson BE
    Hum Mol Genet; 2003 Oct; 12(20):2679-92. PubMed ID: 12944421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic variation in progesterone receptor gene and ovarian cancer risk: A case control study.
    Kanabekova P; Al-Awadi AM; Bauyrzhanova Z; Tahtouh T; Sarray S; Almawi WY
    Gene; 2022 Apr; 820():146288. PubMed ID: 35143942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endometrial cancer and genetic variation in PTEN, PIK3CA, AKT1, MLH1, and MSH2 within a population-based case-control study.
    Lacey JV; Yang H; Gaudet MM; Dunning A; Lissowska J; Sherman ME; Peplonska B; Brinton LA; Healey CS; Ahmed S; Pharoah P; Easton D; Chanock S; Garcia-Closas M
    Gynecol Oncol; 2011 Feb; 120(2):167-73. PubMed ID: 21093899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of the PROGINS PgR polymorphism with susceptibility to female reproductive cancer: A meta-analysis of 30 studies.
    Zhou C; Zou X; Wen X; Guo Z
    PLoS One; 2022; 17(7):e0271265. PubMed ID: 35839271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two estrogen-related variants in CYP19A1 and endometrial cancer risk: a pooled analysis in the Epidemiology of Endometrial Cancer Consortium.
    Setiawan VW; Doherty JA; Shu XO; Akbari MR; Chen C; De Vivo I; Demichele A; Garcia-Closas M; Goodman MT; Haiman CA; Hankinson SE; Henderson BE; Horn-Ross PL; Lacey JV; Le Marchand L; Levine DA; Liang X; Lissowska J; Lurie G; McGrath M; Narod SA; Rebbeck TR; Ursin G; Weiss NS; Xiang YB; Yang HP; Zheng W; Olson SH
    Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):242-7. PubMed ID: 19124504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.